Sonnet BioTherapeutics HoldingsSONN 
$0.85-1.16%24h
-1.16%24h
Global rank35718
Market cap$882.46K
Change 7d14.86%
YTD Performance-51.15%
SP500 benchmarkUnderperform
P/E-0.05
P/S5.97
Revenue$147.81K
Earnings-$18.83M
Dividend yield-
Main Sector
Healthcare
Sonnet BioTherapeutics Holdings (SONN) Total Liabilities
SONN Total Liabilities in 2022: $5.66M
According to Sonnet BioTherapeutics Holdings latest financial reports the total liabilities of SONN is $5.66M, an decrease of -32.42% to 2022. At the end of 2022 company had $8.37M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Sonnet BioTherapeutics Holdings is responsible for during its operational activities.
Sonnet BioTherapeutics Holdings (SONN) Total Liabilities History from 2023 to 2022
-
Value:-
SONN Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $5.66M | -32.42% |
| 2022 | $8.37M | 24.28% |
| 2021 | $6.73M | 35.37% |
| 2020 | $4.97M | 72.41% |
| 2019 | $2.89M | - |
View the Top Total Liabilies Stocks
